The prognostic value of immunoperoxidase staining for proliferating cell nuclear antigen (PCNA) was studied in a series of 140 non-Hodgkin's lymphomas with median follow-up of 9 years. Lymphomas where >50% of cells showed positive staining for PCNA had inferior 5-year survival as compared with those with less than 50% of positive cells (57% vs 41%, P = 0.008). The presence of > 50% of positively staining cells for PCNA was strongly associated with a larger than the median size of the SPF (median, 8.3%) (Christensson et al., 1986 , Young et al., 1987 Lenner et al., 1987; Cowan et al., 1989; Lehtinen et al., 1989) , assessing expression of Ki-67 antigen (Gerdes et al., 1984; Grogan et al., 1988; Hall et al., 1988; Brown et al., 1989) , or by immunocytochemical detection of 5-bromodeoxyuridine (BrdUrd) incorporation in the DNA (Witzig et al., 1989) .
Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma P.J. Klemil, K. Alanen', S. Jalkanen2 & H. Joensuu3
Departments of 'Pathology, and 'Radiotherapy and Oncology, Turku University Hospital, and 2National Public Health Institute, Turku, Finland.
Summary
The prognostic value of immunoperoxidase staining for proliferating cell nuclear antigen (PCNA) was studied in a series of 140 non-Hodgkin's lymphomas with median follow-up of 9 years. Lymphomas where >50% of cells showed positive staining for PCNA had inferior 5-year survival as compared with those with less than 50% of positive cells (57% vs 41%, P = 0.008). The presence of > 50% of positively staining cells for PCNA was strongly associated with a larger than the median size of the SPF (median, 8.3%) , and high histological grade of malignancy (P<0.0001 for both). Lymphomas with both a large percentage (> 50%) of PCNA positive cells and a larger than the median SPF had inferior outcome as compared with lymphomas where either one or both of these factors were small. Although PCNA staining was not an independent prognostic factor in a multivariate analysis, it appears to be supplementary to the SPF even if determined from old paraffin-embedded tissue material.
Treatment of non-Hodgkin's lymphoma is currently based mainly on its histological grade of malignancy, clinical stage and the performance status of the patient. The biological behaviour of lymphoma may also be assessed by determining the rapidity of cell proliferation using various methods, such as measuring the size of the S phase fraction (SPF) by flow cytometry (Christensson et al., 1986 , Young et al., 1987 Lenner et al., 1987; Cowan et al., 1989; Lehtinen et al., 1989) , assessing expression of Ki-67 antigen (Gerdes et al., 1984; Grogan et al., 1988; Hall et al., 1988; Brown et al., 1989) , or by immunocytochemical detection of 5-bromodeoxyuridine (BrdUrd) incorporation in the DNA (Witzig et al., 1989) .
Proliferating cell nuclear antigen (PCNA), also known as cyclin, is a 36 kD nuclear protein (Bravo & Celis, 1980; Bravo et al., 1987 ) that was originally detected by using autoantibodies from sera of patients with SLE (Miyachi et al., 1978) . PCNA is expressed in a high concentration during the S phase fraction of the cell cycle in the nuclei of proliferating cells, and in a lesser amount during the GI and G2/mitosis phases (Kamel et al., 1991) . Several commercially produced antibodies to PCNA are now available, and they may also work on sections prepared from formalin fixed and paraffin-embedded tissue (Hall et al., 1990) . In the present paper we have studied the prognostic value of PCNA staining in an archival series consisting of 140 patients with non-Hodgkin's lymphoma. Table II. routine laboratory procedures, and stored in paper boxes in dark at room temperature (RT). Four micron sections were cut, mounted on polylysin coated glass slides, deparaffinised in xylene and rehydrated through a sequence of decreasing ethanol concentrations, and washed in tris-buffered saline (TBS). The primary antibody, NCL-PCNA clone PCIO (Novocastra Laboratories, Newcastle upon Tyne, Great Britain) in 1% bovine serum albumin (BSA-TBS) was tested at various concentrations, and the dilution of 1: 50 was chosen for the study. Nonspecific binding of the primary antibody was blocked by normal serum. A negative control section was prepared without the PC1O antibody for each tissue section. After 1 h incubation at RT the slides were washed in TBS and treated with ABC complexes (Vectastain, ABC kit mouse IgG PK-4002, Vector Laboratories, Burlingame, CA 94010, USA) and stained with 3,3'-diaminobenzidine tetrahydrochloride (DAB, Polysciences, Inc., Warrington, USA). After washing with TBS, a slight counterstain with Mayer's hematoxylin was carried out to visualise the nuclei not stained with DAB. The staining was successful in all but two cases.
The part of the section that showed most staining was first sought using a low magnification. Flow cytometry and S phase fraction Flow cytometry was done with a FACSscan Flow Cytometer (Becton-Dickinson Immunocytometry Systems, Mountain View, CA) from deparaffinised tissue as described in more detail elsewhere (Joensuu et al., 1991) . DNA was stained with propidium iodide. The SPF was calculated with the rectangular method without any correction for the background debris (Camplejohn et al., 1989) , and in cases with a large DNA index (> 1.4) it was calculated for the aneuploid stemline only. The SPF could not be calculated in seven cases because of the small size of the aneuploid peak (<5,000 particles), overlapping stemlines, or the presence of excessive nuclear debris. The SPF values were also assessed without any knowledge on clinical data.
Statistical analysis Statistical analysis was done using a BMDP computer program (BMDP Statistical Software, Department of Biomathematics, University of California Press, Los Angeles, CA). Survival was estimated with the product-limit method, and comparison of survival between groups was done using the log-rank test (BMDP IL). Survival rate corrected for known intercurrent deaths was used in statistical calculations. The relative importance of prognostic factors was analysed using Cox's proportional hazard model (BMDP 2L). Frequency tables were analysed with the chi-squared test. The Spearman rank correlation coefficient was calculated between the PCNA percentage and the SPF. All P-values are 2-tailed.
Results
Twelve of the 140 lymphomas were entirely negative in PCNA staining. In the rest of the cases (n = 128) from 10 to 100% of the lymphoma cell nuclei stained positively for PCNA (mean, 62%, S.E. 2.5%, median 70%). The staining intensity of the nuclei was scored as negative (grade 0) in 12 cases, weakly positive (grade 1) in 24 cases, clearly positive (grade 2) in 59 cases, and strongly positive (grade 3) in 45 cases (Figure 1 ). There was only little background or cytoplasmic staining present.
Staining intensity for PCNA correlated with mortality in lymphoma. A small subgroup (n = 12) of patients with lymphoma with no staining had 91% 5-year and 81% 10-year survival rates corrected for intercurrent deaths, respectively, whereas lymphomas that had weak to strong staining intensity (n = 128) were associated with only 51% 5-year and 50% 10-year survival rates, respectively (P = 0.03). There was, however, no difference in survival between the staining intensity sceres 1, 2 and 3.
The percentage of cells with positive staining for PCNA showed stronger association with survival than staining intensity. The best cut-off value for the percentage of positively stained cells was 50%, although a 30% cut-off value also produced almost as small a P-value as 50% when tested by the log-rank analysis (P = 0.008 vs 0.009, Figure 2 ). We examined also the prognostic value of the product of the staining intensity score (from 0 to 3) multiplied by the percentage of positively staining cells (from 0 to 100%), but this combined variable (range, from 0 to 300; mean, 130.4; S.E. 7.7) failed to show more prognostic value than the percentage of positively staining cells alone (P = 0.02).
The presence of >50% of positively staining cells for PCNA was strongly associated with a larger than the median size of the SPF (median, 8.3%), and high histological grade of malignancy (P<0.0001 for both, Table I ). Seventy-three percent of low grade malignant lymphomas had less than 50% of lymphoma cells staining positively for PCNA, whereas 80% of lymphomas with high grade of malignancy had > 50% positively staining cells. The association between Working Formulation classification and PCNA staining is shown in Table II . The size of the SPF became larger as the percentage of positively staining cells increased (r = 0.51, P<0.001, Table III ). Twenty (39%) of the DNA aneuploid lymphomas had < 50% nuclei that stained positively for PCNA as compared with 41 (46%) of DNA diploid lymphomas (P = 0.43).
Lymphomas with an SPF larger than the median were associated with unfavourable prognosis (Figure 3) . If the SPF was smaller than 8.3%, and less than 50% of lymphoma cells stained positively for PCNA, 63% of such patients were alive 5 years after the diagnosis, whereas if the SPF was > 8.3% and >50% of lymphoma cells gave a positive staining for for PCNA, only 41% of the patients were alive at 5 years from the diagnosis. If only one of these two factors was large, the 5-year survival rate was poorer than in cases where the SPF was <8.3% and <50% of cells stained positively for PCNA, but better than in cases where the SPF was >8.3% and >50% cells were positive for PCNA ( Figure  4) .
In clinical stages I and II lymphomas with < 50% positively staining nuclei for PCNA (n = 34) had 84% 5-and 10-year survival rates as compared with 54% and 51% among lymphomas with >50% positive nuclei, respectively (n = 39, P = 0.002). The size of the SPF also correlated well with the final outcome in stages I and II. If the SPF was < 8.3% (n = 35) the 5-and 10-year survival rates were 78 and 75%, respectively, and if it was greater than 8.3% (n= 33), both 5-and 10-year survival rates were 54% (P 0.006).
Several factors were associated with survival when they were tested as a single variable (Table IV) . They included Ann Arbor clinical stage (P<0.0001), Working Formulation grading (P = 0.002), and sex (P = 0.01) in addition to the size of the SPF and PCNA staining, but age at the time of the diagnosis, the presence of B symptoms and DNA ploidy did not correlate significantly with survival. When PCNA staining (the percentage of positive nuclei) and the SPF were entered into Cox's multivariate analysis as continuous vari- (Woods et al., 1991) , and low PCNA grading had also been found to be a favourable prognostic factor in other human neoplasms, such as gastric carcinoma (Jain et al., 1991) and haemangiopericytomas (Yu et al., 1991) . Our finding is in line with earlier reports, where a good correlation between PCNA staining and staining for the Ki-67 antibody in nonHodgkin's lymphoma (Hall et al., 1990 , Kamel et al., 1991 , and between PCNA staining and bromodeoxiuridine incorporation in MCF-7 human breast cancer cell line were demonstrated (van Dierendonck et al., 1991 apis the estimated regression coefficient of the hazard function, S.E. is the standard error, and P/S.E.
(z value) describes their significance. "The 95% confidence limits are given for the relative risk of death.
CN.S. = not significant.
it appears to be a better discriminator of survival than staining intensity. Quantitation of PCNA staining may also become more objective by the use of image analysers. Different antibodies to PCNA are available, and it is not certain if they all will show similar association to survival, and other factors, such as the dilution of the antibody may be of importance. We found the dilution 1:50 to work best in our material, which may not be true for other series and for other antibodies (Kamel et al., 1991) . Hence, each laboratory may have to find their own method to assess PCNA staining, and to find their optimal dilution. We used formalin-fixed and paraffin-embedded tissue, which is easily available and makes it possible to assess the association between long-term outcome and PCNA staining.
However, fixation may affect staining for PCNA (van Dierendonck et al., 1991) , and it is not known whether a stronger association between survival and PCNA staining would have been obtained if fresh material had been used. Yet, the results of the present study carried out in a blinded fashion are encouraging, and PCNA staining appears to be of value even if performed from fixed starting material. Moreover, the correlation between the percentage of PCNA stained nuclei and mortality caused by lymphoma may further improve when large series with uniform treatment are investigated.
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